ESR1 and ovarian carcinoma: In breast and ovarian cancers, PFOS has been shown to enhance estrogen receptor (ER) signaling, leading to increased proliferation of mammary gland cells and ovarian epithelial cells, which may contribute to the development of breast and ovarian cancers if left unchecked [26,27,28,29].